Log in here

Retrieve your password

Having issues with the members-only log-in? Try this!


NASEMSO Projects

Military to Civilian EMS Transition

EMS Workforce Planning & Development Guidelines


NASEMSO 2018 Annual Meeting

May 21-24, 2018
Providence, RI


The Washington Update

Apr. 2018
Subscribe to receive the Washington Update via email


State EMS Job Board

Learn about State EMS job opportunities or request that your job listing be posted


Calendar of EMS Industry Events


Search Our Site


E-mail your questions or suggestions about our web site


NASEMSO Internet Policies


Supported by NASEMSO

Supported by NASEMSO: 2018

2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

  • NASEMSO Signs on to Letter Asking Leaders at ASPR/HHS and FDA to Take Action to Ensure the Availability of Essential Emergency Medications (May 16, 2018) In a letter to the Assistant Secretary for Preparedness and Response, Dept. of Health & Human Services, and the Commissioner of the Food & Drug Administration, NASEMSO and six other stakeholder organizations expressed concern about the current shortage of Essential Emergency Medications (EEM), which is threatening lives on a daily basis and leaves the United States unprepared to respond to disasters. The letter asks that the agencies elevate attention to ensuring the availability of EEM for everyday patient needs and ensure the ability to respond to public health emergencies. Download: letter to ASPR/HHS and FDA leaders.
  • NASEMSO Signs on to Letter with Other Stakeholders Asking Senate and House Leaders to Allocate Funds for Both Opioid Overdose Treatment and Prevention Efforts (Mar. 5, 2018) In recent letters to leaders of the U.S. Senate Appropriations Subcommittee on Labor Health & Human Services and to leaders of the U.S. House Appropriations Subcommittee on Labor Health & Human Services, 26 stakeholder organizations (including NASEMSO) who are members of the Injury and Violence Prevention Network encouraged Congress to "support a comprehensive response by allocating funds for both opioid overdose treatment and prevention efforts. While the 21st Century Cures Act provided an initial down payment of $500 million in FY 2017 and FY 2018 for opioid treatment and prevention efforts, none of the funds were appropriated to the Centers for Disease Control and Prevention (CDC), our nation’s lead federal agency for public health and prevention efforts." Download: letter to Senate subcommittee leaders and letter to House subcommittee members.